certain extent. In his landmark paper on the pathological signatures of cerebrovascular amyloid deposition, Stefanos Pantelakis from the Geneva Brain collection, descripted small arterioles and capillaries within the cerebellar cortex affected by this pathology [2] . Similar findings were also reported in a Japanese autopsy study, which found that 14.3% of cerebellar bleeds were associated with cerebral amyloid angiopathy [3] . On the other hand, ruptured and unruptured microaneurysms (miliary aneurysms) associated with intracerebral haemorrhage and hypertension have also been found in the perforating vessels that irrigate the cerebellum (in addition to the basal ganglia, pons, and deep white matter) [4, 5] .
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In a recently published issue of Cerebrovascular Diseases , Jacques De Reuck and his colleagues reported new interesting data on microangiopathies in the cerebellum [6] -another elegant investigation in the sequel of the neuropathological/ 7T postmortem MRI studies performed by the group. In 104 postmortem brains of elderly subjects with various neurodegenerative and cerebrovascular pathologies, cortical cerebellar microbleeds and microinfarcts were detected on 7T MRI of horizontal sections of a cerebellar hemisphere. These microvascular lesions showed the same burden in cases with (n = 15) versus without (n = 73) amyloid angiopathy. The prevalence and load of both lesions were higher only in cases with pure and mixed vascular dementia without amyloid angiopathy (n = 8). These findings were consistent with the Little is known about the neuropathology and clinical relevance of small vessel disease in the cerebellum, which have somehow been neglected and understudied. This is partly reflected, for example, when vascular neurologists or stroke physicians encounter patients with spontaneous (i.e. nontraumatic) parenchymal haemorrhage in the cerebellum -determining the predominant underlying microangiopathy contributing to the bleed is not straightforward. In a rather simplistic, but practical way, sporadic small vessel disease in the brain has been traditionally categorised as either cerebral amyloid angiopathy or 'hypertensive arteriopathy' [1] . Cerebral amyloid angiopathy is a predominantly superficial pathology affecting cortical and leptomeningeal small vessels due to amyloid-β deposition. Hypertensive arteriopathy, an umbrella term including arteriolosclerosis, lipohyalinosis, and fibrinoid necrosis, more often affects the deep arterial perforators (e.g. lenticulostriate) supplying the basal ganglia, thalami and brainstem structures. Paralleling this distribution, it is commonly considered that strictly lobar macrobleeds or microbleeds are more likely related to cerebral amyloid angiopathy, whereas deep bleeds are associated with hypertensive arteriopathy. When it comes to the bottom of the brain, the cerebellum, a similar working hypothesis is currently missing.
Looking back at the original pathological investigations, both cerebral amyloid angiopathy and hypertensive-related damage seem to affect the cerebellum to a neuropathological investigation of the cerebellar hemispheres: more microbleeds and microinfarcts were observed in association with arteriosclerotic leptomeningeal vessels in vascular dementia brains [6] . Of note, the vascular dementia group had a higher prevalence of hypertension and antithrombotic drug use during life. Overall, data presented in the paper are in line with the idea of cerebellar involvement occurring less often and later in the natural history of cerebral amyloid angiopathy than in the cerebrum.
Despite the relatively small sample size of the diagnostic groups, and the potential of selection bias, inherent in any autopsy/MRI study, the paper by Jacques De Reuck et al. is an important modern step in characterising microangiopathy-related cerebellar injury. As the authors comment, these data support the idea of being cautious in attributing cerebellar microbleeds to cerebral amyloid angiopathy as another haemorrhagic manifestation of the disease, a notion currently reflected in the Boston criteria [7, 8] . Further studies are needed to expand their findings and interpretation in cases of spontaneous cerebellar intracerebral haemorrhage [9] with intensive neuropathological investigation, and including postmortem imaging. Until then, in patients with cerebellar signs of small vessel disease (e.g. macro-or micro-bleeds), clinicians might be guided by assessing microangiopathy burden in the whole brain and associated vascular risk factors. Some clinically relevant data can also be extrapolated from other more 'pure' clinical cohorts. For example, in CADASIL, a 'pure' form of small vessel disease and vascular dementia (with affected individuals progressing to dementia at 40-60 years of age), the presence of coexistent Alzheimer's disease pathology and CAA in unlikely: microbleeds frequently occur in the cerebellum and are associated with symptomatic stroke presentation [10, 11] .
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